Artificial Intelligence for Learning Point-of-Care Ultrasound

Sponsor
Stanford University (Other)
Overall Status
Completed
CT.gov ID
NCT05900440
Collaborator
(none)
45
1
2
23.9
1.9

Study Details

Study Description

Brief Summary

Point-of care-ultrasonography has the potential to transform healthcare delivery through its diagnostic and therapeutic utility. Its use has become more widespread across a variety of clinical settings as more investigations have demonstrated its impact on patient care. This includes the use of point-of-care ultrasound by trainees, who are now utilizing this technology as part of their diagnostic assessments of patients. However, there are few studies that examine how efficiently trainees can learn point-of-care ultrasound and which training methods are more effective. The primary objective of this study is to assess whether artificial intelligence systems improve internal medicine interns' knowledge and image interpretation skills with point-of-care ultrasound. Participants shall be randomized to receive personal access to handheld ultrasound devices to be used for learning with artificial intelligence vs devices with no artificial intelligence. The primary outcome will assess their interpretive ability with ultrasound images/videos. Secondary outcomes will include rates of device usage and performance on quizzes.

Condition or Disease Intervention/Treatment Phase
  • Other: Ultrasound with Artificial Inteligence Engabled
  • Other: Ultrasound without Artificial Intelligence Enabled
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Other
Official Title:
Use of Artificial Intelligence for Acquisition of Limited Echocardiograms
Actual Study Start Date :
Jun 1, 2021
Actual Primary Completion Date :
May 30, 2023
Actual Study Completion Date :
May 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Artificial Intelligence Group

Other: Ultrasound with Artificial Inteligence Engabled
Participants shall be randomized 1:1 to receive personal access to a handheld ultrasound device with artificial intelligence vs a device with no artificial intelligence. The groups shall not cross over in which intervention they received.

Active Comparator: Non Artificial Intelligence Group

Other: Ultrasound without Artificial Intelligence Enabled
Participants shall be randomized 1:1 to receive personal access to a handheld ultrasound device with artificial intelligence vs a device with no artificial intelligence. The groups shall not cross over in which intervention they received.

Outcome Measures

Primary Outcome Measures

  1. Time to acquire cardiac ultrasound images [During procedure (300 seconds)]

    This will be measured as the time to acquire a cardiac ultrasound image on a standardized patient, measured in seconds.

Secondary Outcome Measures

  1. Assessment of the quality of captured images [During procedure (300 seconds)]

    Participants will acquire cardiac ultrasound images on a standardized patient. Two reviewers will review the images and provide a numerical assessment of image quality based on the Rapid Assessment for Competency in Echocardiography (RACE) Scale. This is a 0-20 point scale, with higher scores denoting higher image quality (e.g. a better quality image).

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Internal medicine residents rotating on the general inpatient wards service.
Exclusion Criteria:
  • Residents who had taken an ultrasound elective offered by our residency program

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford University School of Medicine Stanford California United States 95403

Sponsors and Collaborators

  • Stanford University

Investigators

  • Principal Investigator: Andre D Kumar, MD, Stanford University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Andre Kumar, Clinical Associate Professor, Stanford University
ClinicalTrials.gov Identifier:
NCT05900440
Other Study ID Numbers:
  • IRB-42094
First Posted:
Jun 12, 2023
Last Update Posted:
Jun 12, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Andre Kumar, Clinical Associate Professor, Stanford University

Study Results

No Results Posted as of Jun 12, 2023